Vantage Galan 3T, MRT-3020, V6.0 with AiCE Reconstruction Processing Unit for MR

The Vantage Galan 3T, MRT-3020, V6.0, is a diagnostic MRI system utilizing 3 Tesla magnetic fields and an AiCE deep learning-based reconstruction unit to generate images by analyzing nuclear magnetic resonance properties of tissues. Its capabilities extend to a wide array of anatomical regions, including head, body, MSK, and cardiac structures, with performance testing indicating equivalent or superior image quality through advanced image processing.

The Canon Vantage Galan 3T, model MRT-3020, V6.0, is a 3 Tesla Magnetic Resonance Imaging (MRI) system designed for diagnostic imaging. It produces cross-sectional images (transaxial, coronal, sagittal, oblique) displaying anatomical structures of the head and body, and is also capable of non-contrast enhanced imaging like Magnetic Resonance Angiography (MRA). The system incorporates an AiCE (Advanced intelligent Clear-IQ Engine) Reconstruction Processing Unit, which employs deep learning technology for image processing across a comprehensive range of anatomical regions including the head, knee, spine (cervical, lumbar, thoracic), various musculoskeletal (MSK) areas (shoulder, hip, elbow, wrist/hand, foot/ankle), pelvis (female, soft tissue, prostate), abdomen (liver, renal, pancreas), breast, and cardiac regions. The MRI images generated correspond to the spatial distribution of protons and their nuclear magnetic resonance (NMR) properties, such as proton density, T1 and T2 relaxation times, flow dynamics, and chemical shift; contrast agents may be utilized as clinically indicated. Performance evaluations of the AiCE deep learning reconstruction have demonstrated maintained or improved low-contrast detectability, signal-to-noise ratio (SNR), and contrast performance through model observer studies. Additionally, a human observer study involving 15 board-certified radiologists/cardiologists and 60 subjects (348 scans) showed a statistical preference for AiCE-processed images over those from other performance filters, indicating that AiCE performs at least as well as, or better than, established reconstruction methods for the supported anatomical applications, without alterations to the system's core hardware or software.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the AiCE deep learning algorithm specifically differentiate between noise and fine anatomical detail across the newly approved diverse anatomical regions (e.g., cardiac vs. MSK)?; What were the specific metrics used in the model observer study to quantify 'maintained or improved low contrast detectability,' and how do these compare to conventional reconstruction techniques?; Were there any specific anatomical regions among the newly added ones where AiCE reconstruction demonstrated a significantly greater improvement in image quality or diagnostic confidence compared to others?; What is the computational overhead or processing time increase associated with using AiCE reconstruction for the newly added, potentially larger or more complex, anatomical regions compared to standard reconstruction methods?; Does the human observer study provide insights into how AiCE impacts diagnostic accuracy or reduces inter-observer variability for specific pathologies within the newly added anatomical regions?